Listed

Rapport Therapeutics, Inc.

RAPPNasdaqCIK 2012593HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q2 FY2026
Operating income−$60.8m, Q2 FY2026
Net income−$56.6m, Q2 FY2026
Line itemUnitperiod not labelled2023-09-30period not labelled2023-12-31period not labelled2024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reportednot reportednot reportednot reportednot reported0.0Revenue, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-210355.Report this figure0.0Revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figurenot reportednot reported20.0Revenue, Q1 FY2026, three months to 2026-03-31$20.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-210355.Report this figure0.0Revenue, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure
Research and development$m7.6Research and development, period not labelled, three months to 2023-09-30$7.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0000950170-24-122801.Report this figure11.8Research and development, period not labelled, three months to 2023-12-31$11.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-11, accession 0000950170-25-036828. Derived: 12-month figure less the 9-month figure.Report this figure12.5Research and development, period not labelled, three months to 2024-03-31$12.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0000950170-25-066393.Report this figure15.7Research and development, Q2 FY2024, three months to 2024-06-30$15.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-104565.Report this figure15.5Research and development, Q3 FY2024, three months to 2024-09-30$15.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-268096.Report this figure17.2Research and development, Q4 FY2024, three months to 2024-12-31$17.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-10, accession 0001193125-26-099360. Derived: 12-month figure less the 9-month figure.Report this figure19.6Research and development, Q1 FY2025, three months to 2025-03-31$19.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-210355.Report this figure22.7Research and development, Q2 FY2025, three months to 2025-06-30$22.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure22.3Research and development, Q3 FY2025, three months to 2025-09-30$22.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-268096.Report this figure30.3Research and development, Q4 FY2025, three months to 2025-12-31$30.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-10, accession 0001193125-26-099360. Derived: 12-month figure less the 9-month figure.Report this figure32.7Research and development, Q1 FY2026, three months to 2026-03-31$32.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-210355.Report this figure51.4Research and development, Q2 FY2026, three months to 2026-06-30$51.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure
Selling, general and administrative$mnot reportednot reportednot reportednot reportednot reportednot reported7.5Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$7.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001193125-26-210355.Report this figure6.8Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$6.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figurenot reportednot reported11.5Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$11.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001193125-26-210355.Report this figure9.4Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$9.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure
Operating income$m(9.6)Operating income, period not labelled, three months to 2023-09-30−$9.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-122801.Report this figure(14.8)Operating income, period not labelled, three months to 2023-12-31−$14.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-11, accession 0000950170-25-036828. Derived: 12-month figure less the 9-month figure.Report this figure(17.1)Operating income, period not labelled, three months to 2024-03-31−$17.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-066393.Report this figure(20.8)Operating income, Q2 FY2024, three months to 2024-06-30−$20.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-104565.Report this figure(21.6)Operating income, Q3 FY2024, three months to 2024-09-30−$21.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268096.Report this figure(23.5)Operating income, Q4 FY2024, three months to 2024-12-31−$23.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099360. Derived: 12-month figure less the 9-month figure.Report this figure(27.1)Operating income, Q1 FY2025, three months to 2025-03-31−$27.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-210355.Report this figure(29.5)Operating income, Q2 FY2025, three months to 2025-06-30−$29.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure(30.0)Operating income, Q3 FY2025, three months to 2025-09-30−$30.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268096.Report this figure(38.5)Operating income, Q4 FY2025, three months to 2025-12-31−$38.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099360. Derived: 12-month figure less the 9-month figure.Report this figure(24.2)Operating income, Q1 FY2026, three months to 2026-03-31−$24.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-210355.Report this figure(60.8)Operating income, Q2 FY2026, three months to 2026-06-30−$60.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure
Income tax$m0.0Income tax, period not labelled, three months to 2023-09-30$1.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-07, accession 0000950170-24-122801.Report this figure0.0Income tax, period not labelled, three months to 2023-12-31$6.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-11, accession 0000950170-25-036828. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(8.7)Net income, period not labelled, three months to 2023-09-30−$8.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-122801.Report this figure(13.5)Net income, period not labelled, three months to 2023-12-31−$13.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-11, accession 0000950170-25-036828. Derived: 12-month figure less the 9-month figure.Report this figure(22.7)Net income, period not labelled, three months to 2024-03-31−$22.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268096.Report this figure(18.1)Net income, Q2 FY2024, three months to 2024-06-30−$18.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268096.Report this figure(17.5)Net income, Q3 FY2024, three months to 2024-09-30−$17.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268096.Report this figure(20.0)Net income, Q4 FY2024, three months to 2024-12-31−$20.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099360. Derived: 12-month figure less the 9-month figure.Report this figure(24.1)Net income, Q1 FY2025, three months to 2025-03-31−$24.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure(26.7)Net income, Q2 FY2025, three months to 2025-06-30−$26.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure(26.9)Net income, Q3 FY2025, three months to 2025-09-30−$26.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268096.Report this figure(33.8)Net income, Q4 FY2025, three months to 2025-12-31−$33.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-10, accession 0001193125-26-099360. Derived: 12-month figure less the 9-month figure.Report this figure(19.9)Net income, Q1 FY2026, three months to 2026-03-31−$19.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure(56.6)Net income, Q2 FY2026, three months to 2026-06-30−$56.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure
Diluted EPS$ per share(5.70)Diluted EPS, period not labelled, three months to 2023-09-30−$5.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0000950170-24-122801.Report this figurenot reported(11.07)Diluted EPS, period not labelled, three months to 2024-03-31−$11.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0000950170-25-066393.Report this figure(1.70)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$1.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-104565.Report this figure(0.50)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.50 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-268096.Report this figurenot reported(0.68)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.68 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-210355.Report this figure(0.75)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.75 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure(0.71)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.71 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-268096.Report this figurenot reported(0.42)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-210355.Report this figure(1.19)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure
Basic EPS$ per share(5.70)Basic EPS, period not labelled, three months to 2023-09-30−$5.70 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0000950170-24-122801.Report this figurenot reported(11.07)Basic EPS, period not labelled, three months to 2024-03-31−$11.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0000950170-25-066393.Report this figure(1.70)Basic EPS, Q2 FY2024, three months to 2024-06-30−$1.70 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-104565.Report this figure(0.50)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.50 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-268096.Report this figurenot reported(0.68)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.68 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-210355.Report this figure(0.75)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.75 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure(0.71)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.71 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-268096.Report this figurenot reported(0.42)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.42 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-210355.Report this figure(1.19)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure

Balance sheet

Cash and equivalents$63.6m, Q2 FY2026
Shareholders' equity$422.9m, Q2 FY2026
Line itemUnitperiod not labelled2023-09-30period not labelled2023-12-31period not labelled2024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m159Cash and equivalents, period not labelled, at 2023-09-30$159.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-122801.Report this figure70.2Cash and equivalents, period not labelled, at 2023-12-31$70.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-11, accession 0000950170-25-036828.Report this figure74.3Cash and equivalents, period not labelled, at 2024-03-31$74.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0000950170-25-066393.Report this figure110Cash and equivalents, Q2 FY2024, at 2024-06-30$110.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-104565.Report this figure39.3Cash and equivalents, Q3 FY2024, at 2024-09-30$39.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-268096.Report this figure56.8Cash and equivalents, FY2024, at 2024-12-31$56.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-10, accession 0001193125-26-099360.Report this figure57.6Cash and equivalents, Q1 FY2025, at 2025-03-31$57.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-210355.Report this figure55.1Cash and equivalents, Q2 FY2025, at 2025-06-30$55.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure251Cash and equivalents, Q3 FY2025, at 2025-09-30$251.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-268096.Report this figure52.6Cash and equivalents, FY2025, at 2025-12-31$52.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure78.1Cash and equivalents, Q1 FY2026, at 2026-03-31$78.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-210355.Report this figure63.6Cash and equivalents, Q2 FY2026, at 2026-06-30$63.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure
Current assets$mnot reported151Current assets, period not labelled, at 2023-12-31$150.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-11, accession 0000950170-25-036828.Report this figurenot reported341Current assets, Q2 FY2024, at 2024-06-30$340.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093334.Report this figure326Current assets, Q3 FY2024, at 2024-09-30$325.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-122801.Report this figure310Current assets, FY2024, at 2024-12-31$309.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-10, accession 0001193125-26-099360.Report this figure291Current assets, Q1 FY2025, at 2025-03-31$291.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066393.Report this figure270Current assets, Q2 FY2025, at 2025-06-30$270.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104565.Report this figure521Current assets, Q3 FY2025, at 2025-09-30$520.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-268096.Report this figure499Current assets, FY2025, at 2025-12-31$498.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure485Current assets, Q1 FY2026, at 2026-03-31$484.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-210355.Report this figure447Current assets, Q2 FY2026, at 2026-06-30$446.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure
Total assets$mnot reported155Total assets, period not labelled, at 2023-12-31$155.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-11, accession 0000950170-25-036828.Report this figurenot reported346Total assets, Q2 FY2024, at 2024-06-30$346.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-093334.Report this figure331Total assets, Q3 FY2024, at 2024-09-30$331.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-122801.Report this figure315Total assets, FY2024, at 2024-12-31$314.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-10, accession 0001193125-26-099360.Report this figure302Total assets, Q1 FY2025, at 2025-03-31$302.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0000950170-25-066393.Report this figure285Total assets, Q2 FY2025, at 2025-06-30$285.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-104565.Report this figure535Total assets, Q3 FY2025, at 2025-09-30$535.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001193125-25-268096.Report this figure512Total assets, FY2025, at 2025-12-31$512.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure498Total assets, Q1 FY2026, at 2026-03-31$497.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-210355.Report this figure459Total assets, Q2 FY2026, at 2026-06-30$459.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure
Current liabilities$mnot reported8.8Current liabilities, period not labelled, at 2023-12-31$8.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-11, accession 0000950170-25-036828.Report this figurenot reported8.1Current liabilities, Q2 FY2024, at 2024-06-30$8.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093334.Report this figure7.1Current liabilities, Q3 FY2024, at 2024-09-30$7.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-122801.Report this figure8.8Current liabilities, FY2024, at 2024-12-31$8.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-10, accession 0001193125-26-099360.Report this figure9.4Current liabilities, Q1 FY2025, at 2025-03-31$9.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066393.Report this figure11.9Current liabilities, Q2 FY2025, at 2025-06-30$11.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104565.Report this figure14.3Current liabilities, Q3 FY2025, at 2025-09-30$14.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-268096.Report this figure19.0Current liabilities, FY2025, at 2025-12-31$19.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure17.9Current liabilities, Q1 FY2026, at 2026-03-31$17.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-210355.Report this figure28.4Current liabilities, Q2 FY2026, at 2026-06-30$28.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure
Total liabilities$mnot reported14.5Total liabilities, period not labelled, at 2023-12-31$14.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-11, accession 0000950170-25-036828.Report this figurenot reported9.2Total liabilities, Q2 FY2024, at 2024-06-30$9.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-093334.Report this figure8.0Total liabilities, Q3 FY2024, at 2024-09-30$8.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0000950170-24-122801.Report this figure9.5Total liabilities, FY2024, at 2024-12-31$9.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-10, accession 0001193125-26-099360.Report this figure16.2Total liabilities, Q1 FY2025, at 2025-03-31$16.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0000950170-25-066393.Report this figure22.0Total liabilities, Q2 FY2025, at 2025-06-30$22.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-104565.Report this figure23.7Total liabilities, Q3 FY2025, at 2025-09-30$23.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001193125-25-268096.Report this figure27.8Total liabilities, FY2025, at 2025-12-31$27.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure26.1Total liabilities, Q1 FY2026, at 2026-03-31$26.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-210355.Report this figure36.1Total liabilities, Q2 FY2026, at 2026-06-30$36.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure
Shareholders' equity$m(13.1)Shareholders' equity, period not labelled, at 2023-09-30−$13.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0000950170-24-122801.Report this figure(25.6)Shareholders' equity, period not labelled, at 2023-12-31−$25.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-10, accession 0001193125-26-099360.Report this figure(39.6)Shareholders' equity, period not labelled, at 2024-03-31−$39.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268096.Report this figure337Shareholders' equity, Q2 FY2024, at 2024-06-30$336.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268096.Report this figure323Shareholders' equity, Q3 FY2024, at 2024-09-30$323.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268096.Report this figure305Shareholders' equity, FY2024, at 2024-12-31$305.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure286Shareholders' equity, Q1 FY2025, at 2025-03-31$285.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure264Shareholders' equity, Q2 FY2025, at 2025-06-30$263.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure512Shareholders' equity, Q3 FY2025, at 2025-09-30$511.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268096.Report this figure485Shareholders' equity, FY2025, at 2025-12-31$484.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure472Shareholders' equity, Q1 FY2026, at 2026-03-31$471.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure423Shareholders' equity, Q2 FY2026, at 2026-06-30$422.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure

Cash flow

Operating cash flow−$41.5m, Q2 FY2026
Capital expenditure$78.0k, Q2 FY2026
Line itemUnitperiod not labelled2023-09-30period not labelled2023-12-31period not labelled2024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(5.4)Operating cash flow, period not labelled, three months to 2023-09-30−$5.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0000950170-24-122801. Derived: 9-month figure less the 6-month figure.Report this figure(10.4)Operating cash flow, period not labelled, three months to 2023-12-31−$10.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-11, accession 0000950170-25-036828. Derived: 12-month figure less the 9-month figure.Report this figure(17.6)Operating cash flow, period not labelled, three months to 2024-03-31−$17.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0000950170-25-066393.Report this figure(16.4)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$16.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-104565. Derived: 6-month figure less the 3-month figure.Report this figure(16.4)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$16.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-268096. Derived: 9-month figure less the 6-month figure.Report this figure(14.4)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$14.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-10, accession 0001193125-26-099360. Derived: 12-month figure less the 9-month figure.Report this figure(20.2)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$20.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-210355.Report this figure(25.1)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$25.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-333862. Derived: 6-month figure less the 3-month figure.Report this figure(17.5)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$17.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-268096. Derived: 9-month figure less the 6-month figure.Report this figure(24.7)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$24.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-10, accession 0001193125-26-099360. Derived: 12-month figure less the 9-month figure.Report this figure(13.1)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$13.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-210355.Report this figure(41.5)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$41.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-333862. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.1Capital expenditure, period not labelled, three months to 2023-09-30$52.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0000950170-24-122801. Derived: 9-month figure less the 6-month figure.Report this figure1.4Capital expenditure, period not labelled, three months to 2023-12-31$1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-11, accession 0000950170-25-036828. Derived: 12-month figure less the 9-month figure.Report this figure1.1Capital expenditure, period not labelled, three months to 2024-03-31$1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0000950170-25-066393.Report this figure1.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$967.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0000950170-25-104565. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2024, three months to 2024-09-30$140.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-268096. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2024, three months to 2024-12-31$226.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-10, accession 0001193125-26-099360. Derived: 12-month figure less the 9-month figure.Report this figure0.3Capital expenditure, Q1 FY2025, three months to 2025-03-31$291.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-210355.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$22.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001193125-26-333862. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$134.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-268096. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2025, three months to 2025-12-31$169.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-10, accession 0001193125-26-099360. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$86.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-210355.Report this figure0.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$78.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001193125-26-333862. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)47.47m, Q2 FY2026
Line itemUnitperiod not labelled2023-06-30period not labelled2023-09-30period not labelled2024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares1.4Diluted shares (weighted), period not labelled, three months to 2023-06-301,440,109 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0000950170-24-093334.Report this figure1.5Diluted shares (weighted), period not labelled, three months to 2023-09-301,529,216 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0000950170-24-122801.Report this figure2.0Diluted shares (weighted), period not labelled, three months to 2024-03-312,046,889 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0000950170-25-066393.Report this figure10.7Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3010,666,528 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0000950170-25-104565.Report this figure34.9Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3034,855,907 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-268096.Report this figure35.3Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3135,266,577 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-210355.Report this figure35.4Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3035,444,635 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure37.9Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3037,931,170 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-268096.Report this figure47.2Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3147,236,618 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-210355.Report this figure47.5Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3047,473,174 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure

Shares outstanding: 47.98mShares outstanding, period not labelled, at 2026-08-0347,978,286 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-333862.Report this figure at Aug 3, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. Listed shows no prices and gives no investment advice.